Clinical Trials
| Cancer Type: Breast | |
| Description: A Randomized Phase III Double-Blind Placebo-Controlled Trial of First-line Chemotherapy and Trastuzumab with or without Bevacizumab for Patients with HER-2/NEU Over-expressing Metastatic Breast Cancer | |
| Entity Approving The Trial: Eastern Cooperative Oncology Group (ECOG) |
|
| Phase: III | |
| Site-Wide Accrual Goal: 489 | |
| Related Files | |
| No related files found. | |
| Related Links | |
| http://www.cancer.gov/search/viewclinicaltrials.aspx?version=healthprofessional&cdrid=561762 |
 |
 |
|
